Breaking free from BMI’s limitations for fair and effective care
The 2023 Clinical Practice Guideline for Evaluation and Treatment of Children and Adolescents with Obesity heralds a new era of evidence-based anti-obesity treatments for children, a cause I wholeheartedly support. However, amidst these advancements, I harbor concerns about the ongoing reliance on the body mass index (BMI) as a screening and diagnostic tool.
Originally designed for population-level assessments, the ease of measuring BMI and its historical precedence has led …
